Home > Products > Human Tumor Cell Lines >

LNCaP, clone FGC

Product Name

LNCaP, clone FGC

Price Get Quote
Product Code







1 vial

Biosafety Level


Shipping Info

Dry Ice


Liquid Nitrogen


The LNCaP cell line was established in 1977 from a metastatic lesion in the left supraclavicular lymph node of a 50-year-old Caucasian male with confirmed prostate carcinoma. These cells can grow either in aggregates or as single cells. LNCaP cells possess a high affinity for androgen receptors and respond to hormonal stimulation. They exhibit aneuploid chromosome numbers ranging from 76 to 91 and express Prostate Specific Antigen (PSA). Unlike other cell lines, LNCaP cells do not form a uniform monolayer but grow in clusters that need to be dissociated through pipetting during subculture. They have a weak attachment to the substrate, do not reach confluence, and rapidly acidify the growth medium. As a result, their growth is very slow.


Why choose LNCaP from AcceGen?

The LNCaP cell from AcceGen offers several key features. It is provided sterile and has been tested to be negative for bacteria, fungi, and mycoplasma, ensuring a clean and reliable culture. The cells undergo professional incubation and cryopreservation processes, guaranteeing high viability upon receipt. Additionally, the product is backed by professional and standardized operations, along with rigorous quality control measures, ensuring consistent and reliable performance for experimental and research purposes.

Recommended Medium And Supplement
Citation Guide

When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).



The LNCaP cell line, derived from human prostate cells, finds application in the development of the CDX (Cell Line Derived Xenograft) LNCaP xenograft mouse model. This model is particularly valuable for studying androgen sensitivity, as LNCaP cells possess a mutated androgen receptor (AR T877A). The LNCaP xenograft model serves as an androgen-dependent system and is utilized for evaluating various treatment modalities targeting the androgen receptor, such as androgen receptor antisense oligonucleotides or bicalutamide. This model provides a platform to investigate the efficacy and mechanisms of action of these interventions in the context of androgen-dependent prostate cancer.

Growth Conditions

37 ℃, 5% CO2

Cell Type


Growth Mode


Product Type

Human Prostate Cancer Cell Lines

Product Image AcceGen Frozen Cells & Cell Lines 1 vial
We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time?

Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
Privacy Policy: AcceGen will never sell, rent, or share your personal information with any third parties without your express permission.
Reviews of LNCaP, clone FGC
AcceGen is always trying to do right by our customers and working hard to build a higher quality product.

Your email address will not be published.

AcceGen Scroll Top Button
Copy link
Powered by Social Snap